NDC 63304-619 - Meloxicam
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63304-619
- Package NDCs from labels
- 63304-619-30, 63304-619-10
- Manufacturer
- Ranbaxy Pharmaceuticals Inc.
- Effective date
- 2007-05-23
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Meloxicam - Ranbaxy Pharmaceuticals Inc. | Ranbaxy Pharmaceuticals Inc. | 2007-05-23 | HUMAN PRESCRIPTION DRUG LABELING |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63304-619-10 | Meloxicam | 1000 in 1 BOTTLE | TABLET | 1000 | 1 | |
| 63304-619-30 | Meloxicam | 30 in 1 BOTTLE | TABLET | 30 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Meloxicam | ACTIVE INGREDIENT | VG2QF83CGL | MELOXICAM (MELOXICAM) TABLET [RANBAXY PHARMACEUTICALS INC.] | 1 | |
| meloxicam | ACTIVE MOIETY | VG2QF83CGL | MELOXICAM (MELOXICAM) TABLET [RANBAXY PHARMACEUTICALS INC.] | 1 | |
| colloidal silicon dioxide | INACTIVE INGREDIENT | MELOXICAM (MELOXICAM) TABLET [RANBAXY PHARMACEUTICALS INC.] | 1 | ||
| crospovidone | INACTIVE INGREDIENT | MELOXICAM (MELOXICAM) TABLET [RANBAXY PHARMACEUTICALS INC.] | 1 | ||
| lactose monohydrate | INACTIVE INGREDIENT | MELOXICAM (MELOXICAM) TABLET [RANBAXY PHARMACEUTICALS INC.] | 1 | ||
| magnesium stearate | INACTIVE INGREDIENT | 70097M6I30 | MELOXICAM (MELOXICAM) TABLET [RANBAXY PHARMACEUTICALS INC.] | 1 | |
| microcrystalline cellulose | INACTIVE INGREDIENT | MELOXICAM (MELOXICAM) TABLET [RANBAXY PHARMACEUTICALS INC.] | 1 | ||
| povidone | INACTIVE INGREDIENT | MELOXICAM (MELOXICAM) TABLET [RANBAXY PHARMACEUTICALS INC.] | 1 | ||
| sodium citrate dihydrate | INACTIVE INGREDIENT | B22547B95K | MELOXICAM (MELOXICAM) TABLET [RANBAXY PHARMACEUTICALS INC.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| MELOXICAM | MELOXICAM | AiPing Pharmaceutical, Inc | f93806e1-88b8-4bcd-ac29-7642ab4d6cbd | 2024-05-02 | Boxed warning, Warnings, Adverse reactions | 311486 152695 |
| meloxicam | MELOXICAM | A-S Medication Solutions | eb5834e0-c6db-4d0f-ae37-9ba2e1aabfdf | 2023-11-26 | Boxed warning, Warnings, Adverse reactions | 311486 |
| meloxicam | MELOXICAM | A-S Medication Solutions | bcfca8c6-bdba-4546-97be-1fc5601c7346 | 2023-09-19 | Boxed warning, Warnings, Adverse reactions | 152695 |
| MELOXICAM | MELOXICAM | NCS HealthCare of KY, LLC dba Vangard Labs | 108397e9-672d-4061-bb74-65818c782d61 | 2023-03-07 | Boxed warning, Warnings, Adverse reactions | 311486 152695 |
| meloxicam | MELOXICAM | Asclemed USA, Inc. | 49367275-4bff-4e36-8a91-e59eb07aa15f | 2022-10-05 | Boxed warning, Warnings, Adverse reactions | 311486 |
| Meloxicam | MELOXICAM | Aphena Pharma Solutions - Tennessee, LLC | e1603665-bbce-48b3-9424-3646570ae9b8 | 2022-08-17 | Boxed warning, Warnings, Adverse reactions | 152695 |
| Meloxicam | MELOXICAM | Proficient Rx LP | b5d72a30-3d32-45ad-be81-3fe601d8912b | 2022-04-01 | Boxed warning, Warnings, Adverse reactions | 311486 152695 |
| Meloxicam | MELOXICAM | Aphena Pharma Solutions - Tennessee, LLC | 432c3937-a4fe-4c92-8452-9ed2dd2cfc9a | 2022-03-03 | Boxed warning, Warnings, Adverse reactions | 311486 |
| Meloxicam | MELOXICAM | Aphena Pharma Solutions - Tennessee, LLC | 9392df66-a152-40e6-b43b-44dc46a23496 | 2021-08-10 | Boxed warning, Warnings, Adverse reactions | 152695 |
| meloxicam | MELOXICAM | Aphena Pharma Solutions - Tennessee, LLC | 10c3949c-0066-4b8a-8d35-937e1ce09bf8 | 2021-08-06 | Boxed warning, Warnings, Adverse reactions | 152695 |
| Meloxicam | MELOXICAM | Aphena Pharma Solutions - Tennessee, LLC | 8f43b954-d1cb-4210-b479-5292c446cc74 | 2021-05-20 | Boxed warning, Warnings, Adverse reactions | 152695 |
| meloxicam | MELOXICAM | Aphena Pharma Solutions - Tennessee, LLC | 966ae650-ad7d-4de1-ab06-54992408fcfd | 2021-03-11 | Boxed warning, Warnings, Adverse reactions | 311486 |
| Meloxicam | MELOXICAM | Aphena Pharma Solutions - Tennessee, LLC | 2a29daa9-74e5-4ed6-b5f1-ce04dc411b26 | 2020-07-20 | Boxed warning, Warnings, Adverse reactions | 152695 |
| Meloxicam | MELOXICAM | Exelan Pharmaceuticals Inc. | dfaac71c-dcc5-4b57-bf3b-616fccab96de | 2018-09-19 | Boxed warning, Warnings, Adverse reactions | 311486 152695 |
| D50815B3-903F-38FC-806F-7B98EF1D6243 | cb44be1a-a5c4-406f-9a2c-1835a2c3f0e0 | 2007-05-23 | Boxed warning, Warnings, Adverse reactions | D50815B3-903F-38FC-806F-7B98EF1D6243 cb44be1a-a5c4-406f-9a2c-1835a2c3f0e0 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.